390 related articles for article (PubMed ID: 15921697)
1. Serum citrulline is a simple quantitative marker for small intestinal enterocytes mass and absorption function in short bowel patients.
Jianfeng G; Weiming Z; Ning L; Fangnan L; Li T; Nan L; Jieshou L
J Surg Res; 2005 Aug; 127(2):177-82. PubMed ID: 15921697
[TBL] [Abstract][Full Text] [Related]
2. [Serum citrulline: a potential marker for intestinal epithelial mass and absorption capacity in short bowel syndrome patients].
Gong JF; Zhu WM; Li N; Liu FN; Tan L; Luo N; Li JS
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Jul; 10(4):333-7. PubMed ID: 17659456
[TBL] [Abstract][Full Text] [Related]
3. Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction.
Crenn P; Messing B; Cynober L
Clin Nutr; 2008 Jun; 27(3):328-39. PubMed ID: 18440672
[TBL] [Abstract][Full Text] [Related]
4. Citrulline blood levels as indicators of residual intestinal absorption in patients with short bowel syndrome.
Santarpia L; Catanzano F; Ruoppolo M; Alfonsi L; Vitale DF; Pecce R; Pasanisi F; Contaldo F; Salvatore F
Ann Nutr Metab; 2008; 53(2):137-42. PubMed ID: 18997462
[TBL] [Abstract][Full Text] [Related]
5. Plasma citrulline concentration: a reliable marker of small bowel absorptive capacity independent of intestinal inflammation.
Papadia C; Sherwood RA; Kalantzis C; Wallis K; Volta U; Fiorini E; Forbes A
Am J Gastroenterol; 2007 Jul; 102(7):1474-82. PubMed ID: 17459021
[TBL] [Abstract][Full Text] [Related]
6. Plasma citrulline is a marker of absorptive small bowel length in patients with transient enterostomy and acute intestinal failure.
Picot D; Garin L; Trivin F; Kossovsky MP; Darmaun D; Thibault R
Clin Nutr; 2010 Apr; 29(2):235-42. PubMed ID: 19744750
[TBL] [Abstract][Full Text] [Related]
7. Poor diagnostic accuracy of a single fasting plasma citrulline concentration to assess intestinal energy absorption capacity.
Peters JH; Wierdsma NJ; Teerlink T; van Leeuwen PA; Mulder CJ; van Bodegraven AA
Am J Gastroenterol; 2007 Dec; 102(12):2814-9. PubMed ID: 17764491
[TBL] [Abstract][Full Text] [Related]
8. [Plasma citrulline concentration--a reliable noninvasive marker of functional enterocyte mass].
Oliverius M; Kudla M; Baláz P; Valsamis A
Cas Lek Cesk; 2010; 149(4):160-2. PubMed ID: 20518248
[TBL] [Abstract][Full Text] [Related]
9. Citrulline and intestinal fatty acid-binding protein: longitudinal markers of postweaning small intestinal function in pigs?
Berkeveld M; Langendijk P; Verheijden JH; Taverne MA; van Nes A; van Haard P; Koets AP
J Anim Sci; 2008 Dec; 86(12):3440-9. PubMed ID: 18708596
[TBL] [Abstract][Full Text] [Related]
10. [Plasma citrulline concentration as a biomarker of intestinal function in short bowel syndrome and in intestinal transplant].
Vecino López R; Andrés Moreno AM; Ramos Boluda E; Martinez-Ojinaga Nodal E; Hernanz Macías A; Prieto Bozano G; Lopez Santamaria M; Tovar Larrucea JA
An Pediatr (Barc); 2013 Oct; 79(4):218-23. PubMed ID: 23528708
[TBL] [Abstract][Full Text] [Related]
11. Citrulline and the gut.
Curis E; Crenn P; Cynober L
Curr Opin Clin Nutr Metab Care; 2007 Sep; 10(5):620-6. PubMed ID: 17693747
[TBL] [Abstract][Full Text] [Related]
12. Plasma citrulline concentration reflects enterocyte mass in children with short bowel syndrome.
Bailly-Botuha C; Colomb V; Thioulouse E; Berthe MC; Garcette K; Dubern B; Goulet O; Couderc R; Girardet JP
Pediatr Res; 2009 May; 65(5):559-63. PubMed ID: 19127207
[TBL] [Abstract][Full Text] [Related]
13. Role of enteral nutrition in adult short bowel syndrome undergoing intestinal rehabilitation: the long-term outcome.
Gong JF; Zhu WM; Yu WK; Li N; Li JS
Asia Pac J Clin Nutr; 2009; 18(2):155-63. PubMed ID: 19713173
[TBL] [Abstract][Full Text] [Related]
14. Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans.
Crenn P; Coudray-Lucas C; Thuillier F; Cynober L; Messing B
Gastroenterology; 2000 Dec; 119(6):1496-505. PubMed ID: 11113071
[TBL] [Abstract][Full Text] [Related]
15. Plasma citrulline concentration as a biomarker for bowel loss and adaptation in hospitalized pediatric patients requiring parenteral nutrition.
Stultz JS; Tillman EM; Helms RA
Nutr Clin Pract; 2011 Dec; 26(6):681-7. PubMed ID: 22205556
[TBL] [Abstract][Full Text] [Related]
16. Rehabilitative therapy of short bowel syndrome: experimental study and clinical trial.
Li N; Zhu W; Guo F; Ren J; Li Y; Wang X; Li J
Zhonghua Wai Ke Za Zhi; 2000 Aug; 38(8):565-9. PubMed ID: 11832109
[TBL] [Abstract][Full Text] [Related]
17. Plasma citrulline concentration: a surrogate end point for radiation-induced mucosal atrophy of the small bowel. A feasibility study in 23 patients.
Lutgens LC; Deutz N; Granzier-Peeters M; Beets-Tan R; De Ruysscher D; Gueulette J; Cleutjens J; Berger M; Wouters B; von Meyenfeldt M; Lambin P
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):275-85. PubMed ID: 15337566
[TBL] [Abstract][Full Text] [Related]
18. The citrulline generation test: proposal for a new enterocyte function test.
Peters JH; Wierdsma NJ; Teerlink T; van Leeuwen PA; Mulder CJ; van Bodegraven AA
Aliment Pharmacol Ther; 2008 Jun; 27(12):1300-10. PubMed ID: 18331613
[TBL] [Abstract][Full Text] [Related]
19. Serum citrulline levels correlate with enteral tolerance and bowel length in infants with short bowel syndrome.
Rhoads JM; Plunkett E; Galanko J; Lichtman S; Taylor L; Maynor A; Weiner T; Freeman K; Guarisco JL; Wu GY
J Pediatr; 2005 Apr; 146(4):542-7. PubMed ID: 15812462
[TBL] [Abstract][Full Text] [Related]
20. Monitoring myeloablative therapy-induced small bowel toxicity by serum citrulline concentration: a comparison with sugar permeability tests.
Lutgens LC; Blijlevens NM; Deutz NE; Donnelly JP; Lambin P; de Pauw BE
Cancer; 2005 Jan; 103(1):191-9. PubMed ID: 15573372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
